Company Information

CIN
Status
Date of Incorporation
27 September 1985
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
26 July 2023
Paid Up Capital
125,330,000
Authorised Capital
250,000,000

Directors

Hemendra Ratilal Shah
Hemendra Ratilal Shah
Manager/Secretary
about 2 years ago
Sumit Gupta
Sumit Gupta
Director/Designated Partner
over 2 years ago
Ankur Janak Shah
Ankur Janak Shah
Director/Designated Partner
over 2 years ago
Srinivas Chidambaram
Srinivas Chidambaram
Director/Designated Partner
over 2 years ago
Nagesh Dinkar Pinge
Nagesh Dinkar Pinge
Director/Designated Partner
over 2 years ago
Maya Janak Shah
Maya Janak Shah
Director/Designated Partner
over 2 years ago
Janak Ramanlal Shah
Janak Ramanlal Shah
Director/Designated Partner
over 2 years ago
Vishal Janak Shah
Vishal Janak Shah
Director/Designated Partner
over 2 years ago
Nipun Sumanlal Mehta
Nipun Sumanlal Mehta
Director/Designated Partner
over 4 years ago
Ved Kumar Jain
Ved Kumar Jain
Director/Designated Partner
over 4 years ago
Sri Krishna Akkipeddi
Sri Krishna Akkipeddi
Director/Designated Partner
over 6 years ago

Past Directors

Prabuddha Prabodhranjan Ganguli
Prabuddha Prabodhranjan Ganguli
Director
over 15 years ago
Bharat Bakhshi
Bharat Bakhshi
Nominee Director
over 17 years ago

Patents

Mct Absorbate Composition And Process For Preparation Thereof

The invention relates to MCT absorbate composition comprising MCT oil, inorganic silicate substrate and at least one excipient which is acceptable in nutraceutical, food and pharmaceutical industry. More preferably MCT absorbate as described herein, is comprised of calcium silicate and at least one excipient selecte...

Pharmaceutical Composition Comprising Dapagliflozin

The present invention relates to solid oral pharmaceutical compositions comprising amorphous dapagliflozin. The invention further relates to a process for the preparation of the said pharmaceutical compositions. The said compositions are administered orally for the treatment of diabetes mellitus. The said compositio...

Curcuminoid Compositions

The present invention relates to compositions comprising one or more curcuminoids, and at least one dissolution enhancer. The said compositions exhibit improved dissolution and are substantially free of surfactants. The said compositions are stable and orally bioavailable. The present invention also provides a proce...

Curcuminoid Composites

The present invention relates to a melt composite comprising one or more curcuminoids and a carrier selected from rice bran extract, mannitol, maltodextrin and mixtures thereof. The invention also provides a process for preparation of the melt composite, wherein the mixture of curcuminoids, rice bran extract, mannit...

Non Staining Curcuminoid Composition

The invention describes a non-staining composition comprising high content of curcuminoids in granular form, which is substantially free of excipients and is comprised of at least about 94% of curcuminoids. The non-staining composition may be comprised of 0 to 5% by weight of excipients, which are used as processing...

Solid Dosage Forms For Oral Co Administration Of Polyphenols And Transition Metal Ions

The present invention provides stable, solid dosage forms for co-administration of two or more, incompatible, active agents wherein one active agent is a polyphenol such as resveratrol and the other active agent is a transition metal ion such as copper. The present invention also provides a process for the preparati...

Gut Protective Compositions Comprising Boswellic Acid

The invention describes a gut-protective composition comprising boswellic acid, at least one pH modifier, wherein the composition exhibits enhanced dissolution. The composition as described herein may be comprised of about 5 to 95% of boswellic acid. The said composition is stable and exhibits improved bioavailabili...

Non Hygroscopic Curing Agents In A Granular Form

The present invention provides a solid, non-hygroscopic curing agent in a powdered / granular form easy to use, handle and optionally reconstitute, comprising a plant-based nitrite derived from a concentrated liquid extract obtained from plant material selected from Beet, radish, onion, celery and chicory leaf. In p...

Stable Liquid Compositions Of Posaconazole

The present invention relates to stable, room-temperature storable, liquid compositions comprising posaconazole. The liquid compositions, when stored at room temperature conditions, exhibit no significant coloration and no significant loss in chemical stability. The liquid compositions also exhibit good dilution sta...

Rivaroxaban Compositions

The present invention relates to non-granulated compositions comprising rivaroxaban for oral administration, wherein rivaroxaban is at a concentration of not more than 20% by weight of the composition. The said non-granulated compositions provide the desired dissolution, and storage stability of rivaroxaban, and are...

Pharmaceutical Composition Comprising Dapagliflozin

The present invention relates to solid oral pharmaceutical compositions comprising amorphous dapagliflozin. The invention further relates to a process for the preparation of the said pharmaceutical compositions. The said compositions are administered orally for the treatment of diabetes mellitus. The said compositio...

Psyllium Formulation With Delayed Gelation Property

The invention relates to granular psyllium formulation comprised of 10 to 60% by weight of gelation retardant, which exhibits delayed gelation property. The invention also relates to the process for preparation of granular formulation, wherein psyllium husk is treated with at least one gelation retardant and optiona...

Non Hygroscopic Water Soluble Curing Agents In A Granular Form

The present invention provides a solid, non-hygroscopic water-soluble curing agent in a powdered / granular form easy to use, handle and optionally reconstitute, comprising a plant-based nitrite derived from a concentrated liquid extract obtained from plant material selected from celery. In particular, it relates to...

Non Colouring Turmeric Formulation And A Process For Preparation Thereof

The present invention relates to a non-colouring turmeric formulation comprised of a blend of turmeric powder and curcumin extract, combined with at least about 10 to 25% by weight of a non-polymeric encapsulating agent and at least one excipient. The formulation may be comprised of blend of turmeric powder and curc...

Prolonged Release Formulation Of Caffeine

The present invention relates to a prolonged release formulation of caffeine, which comprises of caffeine embedded in a continuous phase of non-polymeric release controlling carrier. The formulation may be optionally comprised of one or more excipients which are acceptable in nutraceutical and food industry. The inv...

Angiotensin Receptor Blocker (Arb) Compositions

ANGIOTENSIN RECEPTOR BLOCKER (ARB) COMPOSITIONS The present invention relates to stable, oral compositions comprising at least one angiotensin II receptor blocker (ARB), wherein the ARB is non-granulated. The present invention also relates to stable compositions for oral co-delivery, comprising at least one ARB and...

Modified Release Compositions Comprising Melatonin

Abstract The invention relates to modified release granular composition comprising melatonin and at least one non-swelling release controlling agent. The matrix granular composition as described herein may be specifically comprised of about 1 to 70% by weight of melatonin and about 10 to 70% by weight of non-swelli...

Stable Prolonged Release Formulation Of Vitamin C And A Process For Preparation Thereof

Abstract The invention relates to stable prolonged release vitamin C formulation, which is free of any added stabilizer and exhibits prolonged release of the active. The formulation is comprised of at least one hydrophobic non-polymeric excipient and hydrophilic release controlling agent along with at least one exc...

Modified Release Formulation Comprising Withanolides

Title of the invention: Modified Release Formulation comprising Withanolides Abstract The invention describes a modified release formulation comprising 2 to 10% withanolides, obtained from root powder of Withania somnifera. The formulation is comprised of at least one pH independent release controlling agent o...

Varenicline Compositions

The present invention relates to stable, oral, non-granulated, rapid release compositions comprising varenicline and at least one excipient. The non-granulated compositions are in the form of powder blends, directly compressed tablets, or capsules. The present invention also provides a process for the preparation of...

Acotiamide Compositions

The present invention relates to dosage forms comprising bead compositions of acotiamide for oral administration, wherein the bead composition comprises a core and at least one coat. The bead compositions exhibit immediate release and/or modified release of acotiamide. The oral dosage form may further comprise at l...

Stable Liquid Compositions Of Sugammadex

The present invention relates to photostable and room-temperature storable liquid compositions of sugammadex. The sugammadex liquid compositions comprise sugammadex and a vehicle, and have a dissolved oxygen content of less than about 3 ppm. In preferred liquid compositions, the dissolved oxygen content of the liqui...

Compositions With Reduced Nitrosamine Impurities

The present invention relates to storage-stable pharmaceutical compositions comprising a drug substance containing amine, and at least one excipient, wherein the nitrosamine impurities in the said compositions are within acceptable levels. The nitrite content of the storage-stable pharmaceutical compositions is not ...

Stable Parenteral Compositions Of Parecoxib

The present invention relates to stable, lyophilized compositions comprising parecoxib, for parenteral administration. The lyophilized compositions are capable of being reconstituted in a suitable reconstitution diluent to obtain liquid parecoxib compositions, the said liquid compositions having an in-use stability ...

Pharmaceutical Compositions Comprising Dpp 4 Inhibitor And Sglt Inhibitor

The present invention relates to layered tablet compositions comprising a dipeptidyl peptidase-4 (DPP-4) inhibitor such as teneligliptin, and a sodium glucose cotransporter (SGLT) inhibitor such as dapagliflozin. The said layered tablet compositions comprise lubricant in a concentration of not more than 2% by weight...

Amifampridine Compositions

The present invention relates to rapid release compositions comprising a granular component, wherein the granular component comprises amifampridine phosphate. The present invention also provides a process for the preparation of such compositions.

Registered Trademarks

Narainvi Inventia Healthcare

[Class : 5] Pharmaceuticals And Medical Preparations

Osinviflu Inventia Healthcare

[Class : 5] Pharmaceuticals And Medical Preparations

Nefocalm Inventia Healthcare

[Class : 5] Pharmaceuticals And Medical Preparations.
View +249 more Brands for Inventia Healthcare Limited.

Charges

26 July 2006
Saraswat Co Op Bank Ltd
0
14 January 2002
The Saraswat Co-op. Bank Ltd.
0
04 November 2004
The Saraswat Co-op. Bank Ltd.
0
29 July 2004
The Saraswat Co-op. Bank Ltd.
0
25 February 2004
The Saraswat Co-op. Bank Ltd.
0
18 December 2003
The Saraswat Co-op. Bank Ltd.
0
15 November 2003
The Saraswat Co-op. Bank Ltd.
0
13 November 2003
The Saraswat Co-op. Bank Ltd.
0
17 October 2003
The Saraswat Co-op. Bank Ltd.
0
27 August 2003
The Saraswat Co-op Bank Ltd
0
20 August 2003
The Saraswat Co-op. Bank Ltd.
0
14 February 2002
The Saraswat Co-op. Bank Ltd.
0
02 March 2005
Icici Bank Ltd
0
09 November 2006
Hdfc Bank Limited
0
29 December 2006
The Saraswat Co-operative Bank Ltd
0
29 December 2006
The Saraswat Co-operative Bank Ltd
0
09 February 2007
The Saraswat Cooperative Bank Limited
0
16 March 2007
The Saraswat Cooperative Bank Limited
0
18 May 2007
The Saraswat Cooperative Bank Limited
0
18 June 2007
Hdfc Bank Limited
0
07 August 2007
Hdfc Bank Limited
0
22 August 2007
Icici Bank Limited
0
30 November 2001
Fiat Sundram Auto Finance Ltd.
0
19 February 2008
Barclays Bank Plc
0
13 May 2008
Hdfc Bank Limited
0
08 December 2010
Hdfc Bank Limited
0
23 December 2010
Hdfc Bank Limited
0
24 January 2012
Hdfc Bank Limited
0
25 April 2012
Hdfc Bank Limited
0
09 April 2013
0
11 June 2013
0
25 September 2014
Hdfc Bank Limited
0
26 July 2006
The Saraswat Co Op Bank Ltd
0
16 June 2015
Hdfc Bank Limited
0
26 July 2006
The Saraswat Co Op Bank Ltd
0
27 January 2005
The Saraswat Co-op.bank Ltd
0
18 December 2003
The Saraswat Co-op Bank Ltd.
0
12 March 1996
The Saraswat Co-op. Bank Ltd
0
03 July 1986
The Hongkong & Shanghai Banking Corpo. Ltd.
0
30 March 1992
Maharashtra State Financial Corpo.
0
15 March 1993
The Saraswat Co-op. Bank Ltd.
0
21 April 1993
The Saraswat Co-op. Bank Ltd.
0
03 September 1998
The Saraswat Co-op. Bank Ltd.
0
02 December 1999
The Saraswat Co-op. Bank Ltd.
0
31 May 2019
Others
0
10 January 2006
Hdfc Bank Limited
0
14 July 2015
Hdfc Bank Limited
0
13 October 2014
Hdfc Bank Limited
0
31 October 2007
Hdfc Bank Limited
0
18 September 2019
Citi Bank N.a.
0
18 September 2019
Citi Bank N.a.
0
26 June 2019
Others
0
22 May 2019
Hdfc Bank Limited
0
13 August 2018
Hdfc Bank Limited
0
08 June 2017
Hdfc Bank Limited
0
07 June 2017
Hdfc Bank Limited
0
23 June 2016
Hdfc Bank Limited
0
04 July 2016
Hdfc Bank Limited
0
02 December 2023
Hdfc Bank Limited
0
14 January 2002
The Saraswat Co-op. Bank Ltd.
0
04 November 2004
The Saraswat Co-op. Bank Ltd.
0
29 July 2004
The Saraswat Co-op. Bank Ltd.
0
25 February 2004
The Saraswat Co-op. Bank Ltd.
0
18 December 2003
The Saraswat Co-op. Bank Ltd.
0
15 November 2003
The Saraswat Co-op. Bank Ltd.
0
13 November 2003
The Saraswat Co-op. Bank Ltd.
0
17 October 2003
The Saraswat Co-op. Bank Ltd.
0
27 August 2003
The Saraswat Co-op Bank Ltd
0
20 August 2003
The Saraswat Co-op. Bank Ltd.
0
14 February 2002
The Saraswat Co-op. Bank Ltd.
0
26 July 2006
The Saraswat Co Op Bank Ltd
0
26 July 2006
Saraswat Co Op Bank Ltd
0
09 November 2006
Hdfc Bank Limited
0
29 December 2006
The Saraswat Co-operative Bank Ltd
0
29 December 2006
The Saraswat Co-operative Bank Ltd
0
09 February 2007
The Saraswat Cooperative Bank Limited
0
16 March 2007
The Saraswat Cooperative Bank Limited
0
18 May 2007
The Saraswat Cooperative Bank Limited
0
18 June 2007
Hdfc Bank Limited
0
07 August 2007
Hdfc Bank Limited
0
22 August 2007
Icici Bank Limited
0
02 March 2005
Icici Bank Ltd
0
19 February 2008
Barclays Bank Plc
0
13 May 2008
Hdfc Bank Limited
0
08 December 2010
Hdfc Bank Limited
0
23 December 2010
Hdfc Bank Limited
0
24 January 2012
Hdfc Bank Limited
0
25 April 2012
Hdfc Bank Limited
0
09 April 2013
0
11 June 2013
0
25 September 2014
Hdfc Bank Limited
0
16 June 2015
Hdfc Bank Limited
0
26 July 2006
The Saraswat Co Op Bank Ltd
0
30 November 2001
Fiat Sundram Auto Finance Ltd.
0
27 January 2005
The Saraswat Co-op.bank Ltd
0
18 December 2003
The Saraswat Co-op Bank Ltd.
0
12 March 1996
The Saraswat Co-op. Bank Ltd
0
03 July 1986
The Hongkong & Shanghai Banking Corpo. Ltd.
0
30 March 1992
Maharashtra State Financial Corpo.
0
15 March 1993
The Saraswat Co-op. Bank Ltd.
0
21 April 1993
The Saraswat Co-op. Bank Ltd.
0
03 September 1998
The Saraswat Co-op. Bank Ltd.
0
02 December 1999
The Saraswat Co-op. Bank Ltd.
0
31 May 2019
Others
0
10 January 2006
Hdfc Bank Limited
0
14 July 2015
Hdfc Bank Limited
0
13 October 2014
Hdfc Bank Limited
0
31 October 2007
Hdfc Bank Limited
0
18 September 2019
Citi Bank N.a.
0
18 September 2019
Citi Bank N.a.
0
26 June 2019
Others
0
22 May 2019
Hdfc Bank Limited
0
13 August 2018
Hdfc Bank Limited
0
08 June 2017
Hdfc Bank Limited
0
07 June 2017
Hdfc Bank Limited
0
04 July 2016
Hdfc Bank Limited
0
23 June 2016
Hdfc Bank Limited
0